RxDoctor Payments Data

Kent Johnson

Anatomic Pathology · Ann Arbor, MINPI 1174605117

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $228,900 of the $228,900 with a category attached, or 100.0%. Every reported general payment came from a single manufacturer, Pfizer. Reporting peaked in 2019 at $45,500 and has fallen 93.8% since, to $2,800 in 2025. Among anatomic pathology clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$228,900in general payments, 2019–2025

Across 69 payments — averaging $3317.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$229K
$537,312in research payments, 2019–2025

Across 10 payments — averaging $53,731 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$478K
  • Takeda Pharmaceuticals U.S.A., Inc.$60K

What the payments were for

  • Consulting fees$228,900100%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer69$228,900

How this compares

$228,900 in reported general payments places this provider in the 95th percentile of 36 anatomic pathology providers in Michigan.

See all anatomic pathology providers in Michigan

Other anatomic pathology in Ann Arbor

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →